Capital Research Global Investors Purchases New Position in Addus HomeCare Co. (NASDAQ:ADUS)

Capital Research Global Investors bought a new stake in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 408,048 shares of the company's stock, valued at approximately $51,149,000. Capital Research Global Investors owned about 2.25% of Addus HomeCare at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Smartleaf Asset Management LLC grew its position in shares of Addus HomeCare by 324.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock valued at $35,000 after purchasing an additional 214 shares in the last quarter. Parkside Financial Bank & Trust grew its position in shares of Addus HomeCare by 38.6% in the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after purchasing an additional 148 shares in the last quarter. Meeder Asset Management Inc. purchased a new stake in shares of Addus HomeCare in the fourth quarter valued at approximately $77,000. Harvest Fund Management Co. Ltd acquired a new stake in Addus HomeCare during the fourth quarter worth $86,000. Finally, KBC Group NV increased its stake in Addus HomeCare by 49.1% during the fourth quarter. KBC Group NV now owns 814 shares of the company's stock worth $102,000 after acquiring an additional 268 shares during the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ADUS has been the subject of a number of research analyst reports. Stephens reiterated an "overweight" rating and set a $142.00 price target on shares of Addus HomeCare in a report on Wednesday, March 12th. JMP Securities restated a "market outperform" rating and issued a $150.00 price objective on shares of Addus HomeCare in a report on Tuesday, April 22nd. Oppenheimer boosted their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, January 24th. Macquarie restated an "outperform" rating and issued a $129.00 price objective on shares of Addus HomeCare in a report on Thursday, February 27th. Finally, StockNews.com lowered shares of Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Buy" and a consensus price target of $139.00.

Addus HomeCare Stock Up 1.0 %

NASDAQ:ADUS traded up $1.04 on Friday, reaching $100.58. 97,408 shares of the company's stock were exchanged, compared to its average volume of 162,804. The firm has a market capitalization of $1.83 billion, a price-to-earnings ratio of 23.02, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93. The business has a fifty day moving average of $97.93 and a 200-day moving average of $115.98. Addus HomeCare Co. has a 52-week low of $88.96 and a 52-week high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings data on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. As a group, equities analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.